VD's Model Portfolio & Discussion Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (8684)	3/18/2001 12:23:26 PM
From: Spekulatius	of 9719

Regarding leverage: I see very good leverage with PRCS. Abarelix is on fast track with a therapeutic advantage compared to existing drugs. My guess is that this should make Abarelix the top dog in its category and PRCS gets more than 40% of the profits. Have you ever looked at PRCS proprietary LEAP platform? Do their claims look reasonable?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next